Rx-360 Insights

10+ Year Rx-360 Member Reaches Audit Milestone

July 25, 2022

  The Rx-360 Credit Program is a members-only benefit that GSK has found to be tremendously valuable, as it has generated nearly $100,000 in credits for the science-led global healthcare company. “Not only does Rx-360 […]

Rx-360 Insights

Episode 5: Interview with Best-Selling Author Katherine Eban

July 14, 2022

Host Jim Fries speaks to Katherine Eban, contributing editor for Vanity Fair and a New York Times best-selling author, in the fifth episode of The Patient Safety Podcast. Eban walks Fries through her investigation into […]

Rx-360 Insights

Meet The Board: Kate Silva, MilliporeSigma

June 15, 2022

Kate Silva is the Head of Quality Management Systems and Audits for MilliporeSigma. In this role, she is responsible for overseeing the global life science framework for compliance with quality, regulatory, and industry standards. Kate […]

Rx-360 Insights

Episode 4: Interview with Leigh Verbois, Director of the Office of Drug Security, Integrity and Response for the FDA

June 7, 2022

Host Jim Fries speaks to Leigh Verbois, the Director of the Office of Drug Security, Integrity, and Response for the FDA, in the fourth episode of The Patient Safety Podcast. The episode covers Verbois’ time […]

Publications

Human Blood Origin Materials for Cell & Gene Therapy Manufacturing Supplier Questionnaire

May 24, 2022

Materials derived from human blood such as human serum albumin and transferrin are frequently used either as components of cell culture medium or in other processes. Suppliers of such reagents have incorporated multiple mitigation steps such as sourcing pharmaceutical grade or licensed drug product, sourcing from safe geographical regions, testing for contaminants and inactivation. In addition, this information needs to be available for review during inspections and in regulatory filings. This questionnaire is a comprehensive list of those requirements and will be a useful document for reference.

Rx-360 Insights

Meet The Board: Bill Campagna, Eli Lilly and Company

May 9, 2022

Bill Campagna is the Senior Director of Quality for Procurement and Operations for Eli Lilly and Company; and he’s passionate about serving on Rx-360’s Board of Directors. “I’m proud to be part of Rx-360’s Board […]

Rx-360 Insights

Rx-360 Patient Safety Podcast: Interview with USP CEO Ron Piervincenzi, Ph.D.

April 12, 2022

Rx-360 released the third episode of The Patient Safety Podcast, featuring Ron Piervincenzi, Ph.D., CEO of the United States Pharmacopeia (USP).

Rx-360 Insights

Episode 3: Interview with Ron Piervincenzi, CEO of The United States Pharmacopeia

April 7, 2022

Host Jim Fries speaks to Ron Piervincenzi, Ph.D., CEO of the United States Pharmacopeia (USP), in the third episode of The Patient Safety Podcast. The episode covers topics such as Piervincenzi’s time at USP, the […]

Rx-360 Insights

Episode 2: Interview with Dr. Janet Woodcock, Principal Deputy Commissioner of the FDA

March 1, 2022

For the second episode of the Patient Safety Podcast, host Jim Fries, CEO of Rx-360, speaks to Dr. Janet Woodcock, Principal Deputy Commissioner of the Food and Drug Administration. Throughout the course of their conversation, […]

Rx-360 Insights

Rx-360 Hires 15-Year Communications Veteran as First Head of Marketing & Membership Development

February 15, 2022

Philadelphia, February 14, 2022 — Rx-360, an international pharmaceutical supply chain consortium, is proud to announce that Michael Cavacini has been hired as its first Head of Marketing & Membership Development. As a member of Rx-360’s […]